Principal Investigator
Vishaal Mehra, MD
California Clinical Trials
- 3 trials
- 1 compound
Therapeutic focus
- Major Depressive Disorder
- Dysthymia
- Depression Not Otherwise Specified
- Borderline Personality Disorder
- Obsessive-Compulsive Disorder
All trials (3)
| NCT | Phase | Status | Compound | Sponsor |
|---|---|---|---|---|
| NCT01234558 | Phase 2 | Completed | Rapastinel | Allergan plc |
| NCT01189812 | Phase 2 | Completed | — | Columbia Northwest Pharmaceuticals |
| NCT00758966 | Phase 2 | Discontinued | — | Orexigen Therapeutics, Inc |
Compounds studied
Trial sites (13)
- San Diego, California, United States
- Princeton, New Jersey, United States
- Brooklyn, New York, United States
- Columbia, South Carolina, United States
- Indianapolis, Indiana, United States
- Cincinnati, Ohio, United States
- Bellevue, Washington, United States
- Evanston, Illinois, United States
- Portland, Oregon, United States
- Brown Deer, Wisconsin, United States
- Gainesville, Florida, United States
- Atlanta, Georgia, United States
- National City, California, United States
Investigator and site data mirrored fromClinicalTrials.gov (public domain).